What is Vascor (bepridil hydrochloride)?
Vascor (bepridil hydrochloride) is used to treat chronic stable angina (classic effort-associated angina) due to coronary artery disease. Vascor may be used alone or in combination with beta-blockers and/or nitrates.
Controlled clinical studies have shown an added effect when Vascor is administered to patients already receiving propranolol. Because Vascor has caused serious ventricular arrhythmias, including torsades de pointes type ventricular tachycardia, and the occurrence of cases of agranulocytosis associated with its use, it should be reserved for patients who have failed to respond optimally to, or are intolerant of, other anti-anginal medication.
Common side effects of Vascor include:
- flu-like symptoms,
- muscle aches,
- fever,
- nausea,
- vomiting,
- loss of appetite,
- constipation,
- gas,
- stomach ache,
- dry mouth,
- diarrhea,
- headache,
- fatigue,
- nervousness,
- drowsiness,
- dizziness,
- depression,
- inability to sleep (insomnia),
- blurred vision,
- impotence, and
- reduced sex drive.
Serious side effects of Vascor include:
- very serious cardiac arrhythmias,
- increased or decreased heart rate, and
- other abnormal rhythms.
Drug interactions of Vascor include:
- quinidine,
- procainamide,
- disopyramide,
- flecainide,
- verapamil,
- diltiazem, and
- all beta-blockers, which could seriously reduce contraction of the heart and possibly precipitate congestive heart failure if taken with Vascor.
If Vascor is taken with tricyclic antidepressants it may cause serious problems with abnormal heart rhythms. Vascor may increase levels of digoxin in the blood, thereby increasing the risk of digoxin toxicity. Diuretics may cause a reduction in blood potassium concentrations thereby increasing the risk of Vascor-induced abnormal heart rhythms.
Vascor crosses the placenta, and should not be used during pregnancy unless the benefit to the mother outweighs the potential but unknown risk to the fetus.
Vascor is secreted into breast milk and should not be used by breastfeeding mothers unless the benefit to the mother clearly outweighs the potential but unknown risk to the infant.
What are the important side effects of Vascor (bepridil)?
- Bepridil can cause very serious cardiac arrhythmias. The risk is increased in patients with a specific electrocardiographic abnormality called QT prolongation and in patients with low blood concentrations of potassium or magnesium.
- Bepridil also can cause increased or decreased heart rate and other abnormal rhythms.
Other side effects that can occur among patients taking bepridil include:
Vascor (bepridil) side effects list for healthcare professionals
Adverse reactions were assessed in placebo and active-drug controlled trials of 4-12 weeks duration and longer-term uncontrolled studies. The most common side effects occurring more frequently than in control groups were upper gastrointestinal complaints (nausea, dyspepsia or GI distress) in about 22%, diarrhea in about 8%, dizziness in about 15%, asthenia in about 10% and nervousness in about 7%. The adverse reactions seen in at least 2% of bepridil patients in controlled trials are shown in the following table.
Adverse Reaction | Bepridil HCl (N = 529) | Nifedipine (N = 50) | Propranolol (N = 88) | Diltiazem (N = 41) | Placebo (N = 190) |
---|---|---|---|---|---|
Body as a Whole | |||||
Asthenia | 9.83 | 22.00 | 22.73 | 12.20 | 7.37 |
Headache | 11.34 | 22.00 | 13.64 | 7.32 | 14.21 |
Flu Syndrome | 2.08 | 8.00 | 2.27 | a | 1.05 |
Cardiovascular/Respiratory | |||||
Palpitations | 2.27 | 6.00 | 2.27 | 0.00 | 1.58 |
Dyspnea | 3.59 | 4.00 | 5.68 | 4.88 | 2.11 |
Respiratory Infection | 2.84 | 4.00 | 3.41 | 4.88 | 3.68 |
Gastrointestinal | |||||
Dyspepsia | 6.81 | 4.00 | 5.68 | 4.88 | 1.58 |
G.I. Distress | 4.35 | 10.00 | 6.82 | a | 2.11 |
Nausea | 12.29 | 14.00 | 11.36 | 2.44 | 3.68 |
Dry Mouth | 3.40 | 0.00 | 0.00 | 2.44 | 2.63 |
Anorexia | 3.02 | 0.00 | 2.27 | 0.00 | 1.58 |
Diarrhea | 7.75 | 2.00 | 9.09 | 2.44 | 2.63 |
Abdominal Pain | 3.02 | 4.00 | 1.14 | a | 3.16 |
Constipation | 2.84 | 6.00 | 1.14 | 4.88 | 2.11 |
Central Nervous System | |||||
Drowsy | 3.78 | 4.00 | 4.55 | a | 3.68 |
Insomnia | 2.65 | 6.00 | 3.41 | a | 1.05 |
Dizziness | 14.74 | 30.00 | 10.23 | 4.88 | 9.47 |
Tremor | 4.91 | 4.00 | 0.00 | a | 1.05 |
Tremor of Hand | 3.02 | 4.00 | 0.00 | a | 0.53 |
Paresthesia | 2.46 | 2.00 | 1.14 | 4.88 | 3.16 |
Psychiatric | |||||
Nervous | 7.37 | 16.00 | 1.14 | 2.44 | 3.68 |
a No data available. |
In one twelve week controlled study, daily doses of 200, 300, and 400 mg were compared to placebo. The following table shows the rates of more common reactions (at least 5% in at least one bepridil group).
Adverse Reaction | Bepridil HCl 200 mg (N = 43) | Bepridil HCl 300 mg (N = 46) | Bepridil HCl 400 mg (N = 190) | Placebo (N = 44) |
---|---|---|---|---|
Body as a Whole | ||||
Asthenia | 13.95 | 6.52 | 11.36 | 2.27 |
Headache | 6.98 | 8.70 | 13.64 | 15.91 |
Cardiovascular/Respiratory | ||||
Palpitations | 0.00 | 6.52 | 4.55 | 0.00 |
Dyspnea | 2.33 | 8.70 | 0.00 | 2.27 |
Gastrointestinal | ||||
G.I. Distress | 6.98 | 0.00 | 4.55 | 4.55 |
Nausea | 6.98 | 26.09 | 18.18 | 2.27 |
Anorexia | 0.00 | 2.17 | 6.82 | 2.27 |
Diarrhea | 0.00 | 10.87 | 6.82 | 0.00 |
Central Nervous System | ||||
Drowsy | 6.98 | 6.52 | 0.00 | 4.55 |
Dizziness | 11.63 | 15.22 | 27.27 | 6.82 |
Tremor | 6.98 | 0.00 | 4.55 | 0.00 |
Tremor of Hand | 9.30 | 0.00 | 4.55 | 0.00 |
Psychiatric | ||||
Nervous | 11.63 | 8.70 | 11.36 | 0.00 |
Special Senses | ||||
Tinnitus | 0.00 | 6.52 | 2.27 | 2.27 |
Adverse experiences in long-term open studies were generally similar to those seen in controlled trials.
Although adverse experiences were frequent (at least one being reported in 71% of patients participating in controlled clinical trials), most were well-tolerated. About 15% of patients however, discontinued bepridil treatment because of adverse experiences. In controlled clinical trials, these were principally gastrointestinal (1.0%), dizziness (1.0%) ventricular arrhythmias (1.0%) and syncope (0.6%). The major reasons for discontinuation, with comparison to control agents, are shown below.
Adverse Reaction | Bepridil (N = 515) n (%) | Placebo (N = 288) n (%) | Positive Control (N = 119) n (%) |
---|---|---|---|
Dizziness | 5 (0.97) | 0 (0.0) | 2 (1.68) |
Gastrointestinal Symptoms | 5 (0.97) | 0 (0.0) | 5 (4.20) |
Ventricular Arrhythmia | 5 (0.97) | 0 (0.0) | 0 (0.0) |
Syncope | 3 (0.58) | 0 (0.0) | 0 (0.0) |
Across all controlled and uncontrolled trials, Vascor (bepridil) was evaluated in over 800 patients with chronic angina. In addition to the adverse reactions noted above, the following were observed in 0.5 to 2.0% of the Vascor (bepridil) patients or are rarer, but potentially important events seen in clinical studies or reported in post marketing experience. In most cases it is not possible to determine whether there is a causal relationship to bepridil treatment.
Body as a Whole: Fever, pain, myalgic asthenia, superinfection, flu syndrome.
Cardiovascular/Respiratory: Sinus tachycardia, sinus bradycardia, hypertension, vasodilation, edema, ventricular premature contractions, ventricular tachycardia, prolonged QT interval, rhinitis, cough, pharyngitis.
Gastrointestinal: Flatulence, gastritis, appetite increase, dry mouth, constipation.
Musculoskeletal: Arthritis.
Central Nervous System: Fainting, vertigo, akathisia, drowsiness, insomnia, tremor.
Psychiatric: Depression, anxiousness, adverse behavior effect.
Skin: Rash, sweating, skin irritation.
Special Senses: Blurred vision, tinnitus, taste change.
Urogenital: Loss of libido, impotence.
Abnormal Lab Values: Abnormal liver function test, SGPT increase.
In postmarketing experience with other calcium blockers, gynecomastia has been rarely observed.
Certain cardiovascular events, such as acute myocardial infarction (about 3% of patients) worsened heart failure (1.9%), worsened angina (4.5%), severe arrhythmia (about 2.4% VT/VF) and sudden death (1.6%) have occurred in patients receiving bepridil, but have not been included as adverse events because they appear to be, and cannot be distinguished from, manifestations of the patient's underlying cardiac disease. Such events as torsades de pointes arrhythmias, prolonged QT/QTc, bradycardia, first degree heart block, which are probably related to bepridil, are included in the tables.
What drugs interact with bepridil (Vascor)?
Nitrates: The concomitant use of Vascor (bepridil) with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris. Sublingual nitroglycerin may be taken if necessary for the control of acute angina attacks during Vascor (bepridil) therapy.
Beta-blocking Agents: The concomitant use of Vascor (bepridil) and beta-blocking agents has been well tolerated in patients with stable angina. Available data are not sufficient, however, to predict the effects of concomitant medication on patients with impaired ventricular function or cardiac conduction abnormalities.
Digoxin: In controlled studies in healthy volunteers, bepridil hydrochloride either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum digoxin concentrations. Limited clinical data in angina patients receiving concomitant bepridil hydrochloride and digoxin therapy indicate no discernible changes in serum digoxin levels. Available data are neither sufficient to rule out possible increases in serum digoxin with concomitant treatment in some patients, nor other possible interactions, particularly in patients with cardiac conduction abnormalities.
Oral Hypoglycemics: Vascor (bepridil) has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents.
General Interactions: Certain drugs could increase the likelihood of potentially serious adverse effects with bepridil hydrochloride. In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and procainamide, cardiac glycosides and tricyclic anti-depressants. Anti-arrhythmics and tricyclic anti-depressants could exaggerate the prolongation of the QT interval observed with bepridil hydrochloride. Cardiac glycosides could exaggerate the depression of AV nodal conduction observed with bepridil hydrochloride.
Nitrates: The concomitant use of Vascor (bepridil) with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris. Sublingual nitroglycerin may be taken if necessary for the control of acute angina attacks during Vascor (bepridil) therapy.
Beta-blocking Agents: The concomitant use of Vascor (bepridil) and beta-blocking agents has been well tolerated in patients with stable angina. Available data are not sufficient, however, to predict the effects of concomitant medication on patients with impaired ventricular function or cardiac conduction abnormalities.
Digoxin: In controlled studies in healthy volunteers, bepridil hydrochloride either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum digoxin concentrations. Limited clinical data in angina patients receiving concomitant bepridil hydrochloride and digoxin therapy indicate no discernible changes in serum digoxin levels. Available data are neither sufficient to rule out possible increases in serum digoxin with concomitant treatment in some patients, nor other possible interactions, particularly in patients with cardiac conduction abnormalities.
Oral Hypoglycemics: Vascor (bepridil) has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents.
General Interactions: Certain drugs could increase the likelihood of potentially serious adverse effects with bepridil hydrochloride. In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and procainamide, cardiac glycosides and tricyclic anti-depressants. Anti-arrhythmics and tricyclic anti-depressants could exaggerate the prolongation of the QT interval observed with bepridil hydrochloride. Cardiac glycosides could exaggerate the depression of AV nodal conduction observed with bepridil hydrochloride.
Summary
Vascor (bepridil hydrochloride) is used to treat chronic stable angina (classic effort-associated angina) due to coronary artery disease. Vascor may be used alone or in combination with beta-blockers and/or nitrates. Common side effects of Vascor include flu-like symptoms, muscle aches, fever, nausea, vomiting, loss of appetite, constipation, gas, stomach ache, dry mouth, diarrhea, headache, fatigue, nervousness, drowsiness, dizziness, depression, inability to sleep (insomnia), blurred vision, impotence, and reduced sex drive. Serious side effects of Vascor include very serious cardiac arrhythmias, increased or decreased heart rate, and other abnormal rhythms. Vascor crosses the placenta, and should not be used during pregnancy unless the benefit to the mother outweighs the potential but unknown risk to the fetus. Vascor is secreted into breast milk and should not be used by breastfeeding mothers unless the benefit to the mother clearly outweighs the potential but unknown risk to the infant.
Multimedia: Slideshows, Images & Quizzes
-
Heart Disease: Causes of a Heart Attack
Heart disease prevention includes controlling risk factors like diet, exercise, and stress. Heart disease symptoms in women may...
-
Heart Disease: Foods That Are Bad for Your Heart
If you want a healthy ticker, there are some foods you’ll want to indulge in every now and then only. Find out which ones and how...
-
Am I Having a Heart Attack? Symptoms of Heart Disease
Heart attacks symptoms vary greatly for men and women, from anxiety and fatigue to nausea and sweating. Learn the warning signs...
-
Heart Disease: Symptoms, Signs, and Causes
What is heart disease (coronary artery disease)? Learn about the causes of heart disease, arrhythmias and myopathy. Symptoms of...
-
Cardiac Arrest: What You Should Know
Cardiac arrest is a serious medical emergency that requires immediate medical care. Use this WebMD slideshow to know whether you...
-
Heart Disease Quiz: Test Your Medical IQ
Take our Heart Disease Quiz to get answers and facts about high cholesterol, atherosclerosis prevention, and the causes,...
Related Disease Conditions
-
Heart Disease: Sudden Cardiac Death
Second Source WebMD Medical Reference
-
Heart Disease
Heart disease (coronary artery disease) occurs when plaque builds up in the coronary arteries, the vessels that supply blood to the heart. Heart disease can lead to heart attack. Risk factors for heart disease include: Smoking High blood pressure High cholesterol Diabetes Family history Obesity Angina, shortness of breath, and sweating are just a few symptoms that may indicate a heart attack. Treatment of heart disease involves control of heart disease risk factors through lifestyle changes, medications, and/or stenting or bypass surgery. Heart disease can be prevented by controlling heart disease risk factors.
-
Angina
Angina is chest pain due to inadequate blood supply to the heart. Angina symptoms may include chest tightness, burning, squeezing, and aching. Coronary artery disease is the main cause of angina but there are other causes. Angina is diagnosed by taking the patient's medical history and performing tests such as an electrocardiogram (EKG), blood test, stress test, echocardiogram, cardiac CT scan, and heart catheterization. Treatment of angina usually includes lifestyle modification, medication, and sometimes, surgery. The risk of angina can be reduced by following a heart healthy lifestyle.
-
Herpangina
Herpangina is a contagious illness often seen in children. It is caused by a Coxsackievirus or an enterovirus. Symptoms and signs include mouth sores, fever, and sore throat. Treatment focuses on alleviating fever and pain with acetaminophen and ibuprofen. It is important for children to stay well hydrated, as children may be resistant to eating or drinking.
-
Stress and Heart Disease
Stress itself may be a risk factor for heart disease, or high levels of stress may make risk factors for heart disease worse. The warning signs of stress can be physical, mental, emotional, or behavioral. Check out the center below for more medical references on stress and heart disease, including multimedia (slideshows, images, and quizzes), related diseases, treatment, diagnosis, medications, and prevention or wellness.
-
Heart Disease in Women
Heart disease in women has somewhat different symptoms, risk factors, and treatment compared to heart disease in men. Many women and health professionals are not aware of the risk factors for heart disease in women and may delay diagnosis and treatment. Lifestyle factors such as diet, exercise, tobacco use, overweight/obesity, stress, alcohol consumption, and depression influence heart disease risk in women. High blood pressure, high cholesterol, and diabetes also increase women's risk of heart disease. Electrocardiogram (EKG or ECG), stress-ECG, endothelial testing, ankle-brachial index (ABI), echocardiogram, nuclear imaging, electron beam CT, and lab tests to assess blood lipids and biomarkers of inflammation are used to diagnose heart disease. Early diagnosis and treatment of heart disease in women saves lives. Heart disease can be prevented and reversed with lifestyle changes.
-
Smoking and Heart Disease
Smoking increases the risk of heart disease in women and men. Nicotine in cigarettes decrease oxygen to the heart, increases blood pressure, blood clots, and damages coronary arteries. Learn how to quit smoking today, to prolong your life.
-
Heart Disease Treatment in Women
Heart disease treatment in women should take into account female-specific guidelines that were developed by the American Heart Association. Risk factors and symptoms of heart disease in women differ from those in men. Treatment may include lifestyle modification (diet, exercise, weight management, smoking cessation, stress reduction), medications, percutaneous intervention procedure (PCI), and coronary artery bypass grafting (CABG). Heart disease is reversible with treatment.
Treatment & Diagnosis
- Heart Disease FAQs
- Beta Carotene Supplements Not the Answer for Cancer or Heart Disease
- Heart Disease Risks Reduced With Running
- Heart Risks - Reduced By Walking & Vigorous Exercise
- Heart Disease In Women
- Ramipril, Heart Disease, Stroke & Diabetes
- Heart Disease & Stroke - Progress
- Heart Disease Stroke and Diabetes
- Heart Disease - Lessons Learned From Pitcher's Early Death
- Heart Disease: Antioxidant Supplements and Women
- Heart Disease Risk and C-reactive Protein (CRP)
- Hormone Therapy and and Heart Disease in Women
- Angina: Don't Take It Lightly
- How Long Does Herpangina Last in Children?
- What are The Complications of Rheumatic Heart Disease?
- Can I Still Get Heart Disease if I Take Blood Pressure Medication?
- Do I Have Angina?
- Does Hashimoto's Affect Heart Disease and Osteoporosis?
- Heart Disease Prevention in Women
- Angina Diagnosis
- Angina Symptoms
- Heart Healthy Diet: Hypertension & Heart Disease
Medications & Supplements

Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.